Page last updated: 2024-08-25

dicetylphosphate and B16 Melanoma

dicetylphosphate has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asai, T; Dewa, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsuruta, A; Yonenaga, N1
Ando, H; Asai, T; Dewa, T; Hatanaka, K; Ishii, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsukada, H; Urita, Y; Yonenaga, N1

Other Studies

2 other study(ies) available for dicetylphosphate and B16 Melanoma

ArticleYear
RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-10, Volume: 160, Issue:2

    Topics: Animals; Cations; Cell Line, Tumor; Drug Carriers; Ethylenediamines; Genetic Therapy; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Organophosphates; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays

2012
Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:2

    Topics: Animals; Cell Proliferation; Ethylenediamines; Liposomes; Lung; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organophosphates; Peptides, Cyclic; Polyethylene Glycols; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Salivary alpha-Amylases; Vascular Endothelial Growth Factor A

2013